<DOC>
	<DOCNO>NCT01574625</DOCNO>
	<brief_summary>A Single Center Non-Interventional Post-Market Release , Long Term Follow Up study patient underwent Isolated Aortic Valve Replacement Isolated Mitral Valve Replacement Medtronic Mosaic Bioprosthesis . The purpose study evaluate long term safety , efficacy clinical performance Mosaic Bioprostheses .</brief_summary>
	<brief_title>Post-Approval Study MOSAICÂ® Bioprostheses</brief_title>
	<detailed_description>Objectives : The primary objective study evaluate long-term safety , efficacy clinical performance . Study Design : This prospective , single center , non-interventional , non-randomized , post-market release clinical study Sample Size Study Duration : A total 255 patient aortic valve replacement 47 patient mitral valve replacement Albertinen-Krankenhaus ( Hamburg , Germany ) previous Mosaic Pre-Market approval ( PMA ) study . All survive patient Mosaic Pre-Market Approval study center , invited participate . Approximately 225 patient invite . This study intend serve ongoing source information long-term durability safety CE-marked Medtronic Mosaic bioprosthesis . As study continue indefinitely last follow-up visit ( patient study exit due patient death , withdrawal patient consent , ... ) last study patient . PATIENT SELECTION : Inclusion criterion : - All patient enrol implanted Mosaic bioprosthesis Albertinen-Krankenhaus ( Hamburg , Germany ) previous Mosaic PMA study , invite participate long- term follow-up study . - Patients able provide inform consent Exclusion criterion : - Patients Albertinen-Krankenhaus ( Hamburg , Germany ) participate Mosaic PMA study ineligible study . - Patients refuse able provide inform consent . - Patients willing unable comply Clinical Investigation Plan ( CIP ) -requirements . Data Requirements analysis : For patient enrol study , information collect annually . Data collect patient status device hemodynamic performance echocardiography . Patient identity anonymized . Appropriate statistical analysis perform collected clinical data .</detailed_description>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<mesh_term>Mitral Valve Stenosis</mesh_term>
	<criteria>All patient enrol implanted Mosaic bioprosthesis AlbertinenKrankenhaus ( Hamburg , Germany ) previous Mosaic PMA study , invite participate longterm follow study . Patients able provide inform consent Patients AlbertinenKrankenhaus ( Hamburg , Germany ) participate Mosaic PMA study ineligible study . Patients refuse able provide inform consent . Patients willing unable comply CIPrequirements</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>